Insmed
INSM
#1043
Rank
NZ$39.95 B
Marketcap
NZ$184.31
Share price
-0.17%
Change (1 day)
8.31%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2026 (TTM): -NZ$1.88 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$0.81 Billion. In 2025 the company made an earning of -NZ$2.07 Billion a decrease over its 2024 earnings that were of -NZ$1.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.88 Billion-9.18%
2025 -NZ$2.07 Billion43.91%
2024 -NZ$1.44 Billion23.71%
2023 -NZ$1.17 Billion45.77%
2022 -NZ$0.8 Billion15.83%
2021 -NZ$0.69 Billion50.19%
2020 -NZ$0.46 Billion16.4%
2019 -NZ$0.4 Billion-23.9%
2018 -NZ$0.52 Billion59.35%
2017 -NZ$0.33 Billion8.52%
2016 -NZ$0.3 Billion47.25%
2015 -NZ$0.21 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$95.02 Million35.14%
2012 -NZ$70.31 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$10.82 Million-105.22%
2009 NZ$0.20 B-905.06%
2008 -NZ$25.73 Million-27.31%
2007 -NZ$35.39 Million-62.41%
2006 -NZ$94.14 Million98.19%
2005 -NZ$47.5 Million0.03%
2004 -NZ$47.49 Million159.07%
2003 -NZ$18.33 Million-69.31%
2002 -NZ$59.72 Million
2000 -NZ$53.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.32 B-1,532.77%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$18.57 B-1,073.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.76 B-559.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$42.35 M-102.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$40.24 Million-97.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
-NZ$40.71 Million-97.87%๐Ÿ‡บ๐Ÿ‡ธ USA